Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000039529Phase 4Recruiting
Phase 4, open-label, single-arm trial of esketamine, sponsored by Xiamen Maternal and Child Health Care Hospital. Primary endpoints: Plasma concentration of esketamine and Plasma concentration of S-demethyl ketamine. Started Dec 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000039529.